IVC Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
IVC Wealth Advisors's BMY Position: Q2 2026 in Review
IVC Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.12% in Q2 2026, buying an estimated $345 and bringing the position to 5,201 shares worth $300K. The position accounts for 0.12% of the portfolio, ranked #138.
IVC Wealth Advisors first reported a position in BMY in Q4 2020 and has held it in 22 quarters since. The position peaked at $689K in Q2 2022. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- IVC Wealth Advisors held 5,201 shares of Bristol-Myers Squibb worth $300K as of Q2 2026.
- IVC Wealth Advisors bought 6 Bristol-Myers Squibb shares in Q2 2026, an estimated $345.
- Bristol-Myers Squibb made up 0.12% of IVC Wealth Advisors's portfolio in Q2 2026, its #138 holding.
- IVC Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 22 quarters since.
- IVC Wealth Advisors's Bristol-Myers Squibb position peaked at $689K in Q2 2022.
- 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on IVC Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.